Skip to main content
. 2023 May 12:1–19. Online ahead of print. doi: 10.1038/s41573-023-00692-8

Fig. 4. A typical cascade approach for antiviral screening.

Fig. 4

After the initial primary enzymatic assays, a high-throughput tier 1 cellular assay is used to drive medicinal chemistry, and a lower-throughput tier 2 assay is used to predict human dose. A549-hACE2, A549 cell line overexpressing human angiotensin-converting enzyme 2; HAEC, human airway epithelial cell; iPSC, induced pluripotent stem cell; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.